The Department of Health and Human Services (HHS) has canceled a nearly $600 million contract with Moderna to develop pandemic flu vaccines. This decision, while anticipated after a February review, is considered a setback for US pandemic preparedness. Moderna's mRNA vaccine platform, though fast, faces opposition from some, impacting the nation's ability to rapidly produce flu vaccines in a future pandemic.

Prepared by Olivia Bennett and reviewed by editorial team.